Latest Fundraising News

Zeus Resources Ltd has successfully reinstated its securities on the ASX and raised over $1.2 million through a Share Purchase Plan, Priority Options Offer, and Placement, advancing exploration in uranium, lithium, and rare earth projects across South Australia and Western Australia.

Stavely Minerals reported a $1.593 million net cash outflow for Q4 2024 but plans to reduce exploration expenditure in the coming quarter to preserve its $2.673 million cash balance.

Jupiter Energy Limited reported steady oil sales revenue of approximately US$1.76 million for Q4 2024, driven entirely by domestic channels, alongside commissioning a key gas utilisation project and launching a $4 million capital raise.

Strategic Energy Resources has completed a significant 25-hole drill program at its Achilles 1 Prospect, confirming widespread polymetallic mineralisation, while a new electromagnetic survey at its Mundi Project reveals promising conductors for further exploration.

Imugene Limited has secured A$20 million through convertible notes as part of a broader A$46 million capital raise, aiming to advance its promising immuno-oncology pipeline.

Canyon Resources has locked in a $124 million underwriting agreement with major shareholder Eagle Eye Asset Holdings to finance critical rolling stock for its Minim Martap bauxite project in Cameroon, marking a pivotal step towards production.

Zelira Therapeutics has received a fourth funding tranche, bringing total investment to US$3.25 million to support FDA clinical trials of its HOPE® 1 cannabinoid medicine targeting irritability in autism spectrum disorder and Phelan-McDermid Syndrome.

Sagalio Energy Limited reported a net cash outflow of USD 79,000 in Q4 2024, ending the quarter with only USD 42,000 in cash and limited financing facilities. The company’s funding runway now stands at just over two quarters, raising questions about its near-term financial strategy.

Antares Metals Limited reported a net cash outflow of $704,000 for the December 2024 quarter, driven by operating expenses, while maintaining a healthy cash balance of nearly $3 million.

Icetana Limited has announced a fully underwritten renounceable entitlement offer to raise approximately $2.65 million, aiming to bolster sales, marketing, and product development efforts. The offer, priced at $0.02 per new share, opens on February 3 and closes on February 14, 2025.

NeuRizer Ltd has completed a $150,000 private share placement, issuing 100 million new shares to support its NeuRizer Urea Project and general working capital needs.

Zeus Resources has successfully placed the shortfall in its Priority Options Offer, bringing total funds raised to nearly $200,000. The move reflects solid shareholder backing ahead of the company’s next growth phase.